Team

All team members

Counsel

Dr Thomas Friede

Counsel

German Patent Attorney

European Patent Attorney

Biochemist

As a German and European patent attorney, Thomas Friede has more than 15 years of experience with inventions in the fields of life sciences, pharmaceuticals and biotechnology. His earlier doctoral research was carried out at the German Cancer Research Center (DKFZ).

The focus of his work as a patent attorney is on patent grant and patent enforcement proceedings and includes opposition and appeal proceedings before the EPO as well as nullity actions before the Federal Patent Court. Working together with specialized lawyers, Thomas Friede advises and represents clients in infringement proceedings before the regional courts. 

Thomas Friede has wide-ranging litigation experience in drug-releasing stents, diagnostic assays, cosmetics, vaccines and antibodies.

T

+49 (0)89 747 266 0

F

+49 (0)89 776 424

E

Friede@maiwald.eu
Contact data VCF | Vita PDF

Since 2021
Counsel at Maiwald
Since 2019
Patent attorney at Maiwald
2002-2018
Patent attorney at IP law firms
1998-2002
Patent attorney trainee at an IP law firm

2002
Admitted to practice as a European patent attorney
2002
Admitted to practice as a German patent attorney
1999-2002
Studied law for patent attorneys at the University of Hagen
1993-1996
Doctoral degree in biochemistry from the Eberhard Karls University of Tübingen (doctoral research at the German Cancer Research Center (DKFZ) Heidelberg)
1987-1993
Studied biochemistry at the Eberhard Karls University of Tübingen

  • Opposition and nullity proceedings
  • Patent litigation
  • Patent examination proceedings and portfolio management
  • Application strategies and drafting of patent applications
  • Freedom-to-operate- and validity opinions
  • Process for obtaining supplementary protection certificates

  • Recommended in IAM Patent 1000 “World’s Leading Patent Professionals” 2012, 2013, 2014, 2015

  • Stem-cell ruling provides perspective, The Patent Lawyer Magazine, 03/2013
  •  ECJ: no patent protection for human embryonic stem-cell related inventions, ipeg, 10/2011
  • Tagungsband zum Symposium Sektoruntersuchung Pharma der Europäischen Kommission – Kartellrechtliche Disziplinierung des Patentsystems?, Carl Heymanns Verlag, 2010
  • Tagungsband zum Symposium Stammzellforschung – Quo Vadis?, Carl Heymanns Verlag, 2009
  • Patentreform, BIO forum 08/2007
  • The other EPO battle, Managing Intellectual Property, 05/2007
  • Reinventing the patent, Pharma Technology (English/Chinese), 2007
  • Patente auf Diagnostika, Transkript, 06/2006
  • EPO: Is there a doctrine of exhaustion of priority rights, Pharmaceutical Law Insight, 04/2006 (together with Birgit Strube)
  • Disclaimers in Patent Claims, European Biotechnology Science & Industry News, 04/2005
  • What kind of protection can you get? On method of treatment inventions, Biotechology Law Report, 06/2000 (together with Franz-Josef Zimmer)

  • German Patent Attorney Association
  • epi
  • VPP
  • FICPI

  • German
  • English
  • French